KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
03.01.19 - NovaSterilis brings the technology of supercritical CO2 processing into laboratories at a benchtop scale that is practical and affordable...more
02.12.19 - Vector and Via partner to establish Global Data Asset Collaborative (GDAC), a multi-company transformer database...more
01.02.19 - GNS Co-Founder discussed how AI will power the future of in silico clinical trials...more
09.06.18 - Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer...more
08.16.18 - Via CEO presents at 2018 Energy Impact Partners Roundtable and Iberdrola's Innoday...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.330.2319